We serve 2-Mercaptopyridine CAS:2637-34-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | Yellow crystal | Conform |
| Loss on drying | ≤1.0% | 0.06% |
| Assay | ≥98.0% | 98.56% |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like 2-Mercaptopyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-pyridinethiol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Pyridinethiol,2-Pyridyl mercaptan Use and application,2-mercapto-pyridine technical grade,usp/ep/jp grade.
Related News: The Transport Security Administration (TSA) will issue a new security directive to airlines from Sunday, according to a person briefed on the restrictions.N-{5-benzylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}-2-fluorobenzamide manufacturer We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.2-Methyl-ceramidonin-carbonsaeure-(8) supplier Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.1-(2-fluoro-4-hydroxy-3-(hydroxymethyl)but-2-en-1-yl)pyrimidine-2,4(1H,3H)-dione vendor Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.
